As tumours increase in size, the accompanying increased demand for nutrients and oxygen upregulates the excess production of pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) from tumour cells, termed the ‘angiogenic switch’ (2). This evidence concerns the gene VEGFA and neoplasm.